DME Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VSNT
Versant Media Group
VSNT
|
+$102M |
| 2 |
TD Synnex
SNX
|
+$66.6M |
| 3 |
Crocs
CROX
|
+$57.3M |
| 4 |
Resideo Technologies
REZI
|
+$56.2M |
| 5 |
SLM Corp
SLM
|
+$49.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kyndryl
KD
|
+$101M |
| 2 |
Weatherford International
WFRD
|
+$56.3M |
| 3 |
Warner Bros
WBD
|
+$44.2M |
| 4 |
Fluor
FLR
|
+$37.7M |
| 5 |
Global Payments
GPN
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.11% |
| 2 | Healthcare | 15.41% |
| 3 | Energy | 13.03% |
| 4 | Industrials | 10.34% |
| 5 | Financials | 7.7% |
Similar funds
DME Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, DME Capital Management held 52 positions worth $3.19B, up 12% from $2.85B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
DME Capital Management deployed $285M of net new capital in Q1 2026, opening 11 new positions and adding to 15 existing holdings. Its largest new stake was Versant Media Group: 3,028,615 shares worth $112M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 38% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Weatherford International, an estimated $56.3M trimmed.
- DME Capital Management's largest Q1 2026 buy was Versant Media Group: 3,028,615 shares worth $112M.
- DME Capital Management added most to TD Synnex in Q1 2026, an estimated $66.6M increase.
- DME Capital Management's biggest Q1 2026 reduction was Weatherford International, cutting an estimated $56.3M.
- DME Capital Management fully exited Kyndryl in Q1 2026, selling an estimated $101M.
- DME Capital Management's ten largest holdings make up 57% of its $3.19B portfolio in Q1 2026.
- DME Capital Management opened 11 new positions and closed 7 in Q1 2026.
- DME Capital Management's portfolio value rose 12% quarter-over-quarter to $3.19B.
Based on DME Capital Management's 13F filing for Q1 2026, filed 15 May 2026.